RecruitingNot ApplicableNCT06212193

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium™ Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)

Sponsor

Innoventric LTD

Enrollment

15 participants

Start Date

Aug 5, 2024

Study Type

INTERVENTIONAL

Conditions

Tricuspid Regurgitation Tricuspid Regurgitation Functional

Summary

Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Trillium™ for people with tricuspid regurgitation and tricuspid regurgitation functional. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETrillium™

Trillium™ Stent Graft for Cross-Caval Tricuspid Valve Replacement

Locations(12)

Cardiovascular Institute of Los Robles Health System

Thousand Oaks, California, United States

Ascension St. John

Detroit, Michigan, United States

Mayo Clinic Hospital (Rochester)

Rochester, Minnesota, United States

Weill Cornell Medicine

New York, New York, United States

Stony Brook Heart Institute

Stony Brook, New York, United States

The Christ Hospital

Cincinnati, Ohio, United States

Lankenau Heart Institute

Philadelphia, Pennsylvania, United States

TriStar Centennial Medical Center

Nashville, Tennessee, United States

University of Washington Medical Center

Seattle, Washington, United States

University Medicine Mainz

Mainz, Rhineland-Palatinate, Germany

Helios Health Institute GmbH, Leipzig

Leipzig, Saxony, Germany

German Heart Center at Charité (DHZC)

Berlin, State of Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06212193

Related Trials

Laplace Early Feasibility Study - Canada

NCT071710603 locations

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

NCT0618368410 locations

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

NCT0409714579 locations

TTVR Early Feasibility Study

NCT0443306520 locations

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

NCT055564602 locations